Shady Adnan-Awad

8PUBLICATIONS
60CO-AUTHORS
Haematological tumoursRegenerative medicine (incl. stem cells)Molecular targetsMedical infection agents (incl. prions)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Oct 09, 2026
RUNX1 aberrations in blast-phase chronic myeloid leukaemia induce the RNA-binding protein SPATS2L, which promotes growth, survival and stress granule assembly.

|Sep 16, 2025
Granulocyte abundance and maturation state at diagnosis predicts treatment-free remission in CML.

Mikko Purhonen, Mikael Tatun, Katariina Luukkainen

|Jan 10, 2025
High-throughput drug screening identifies SMAC mimetics as enhancers of NK-cell cytotoxicity in chronic myeloid leukemia.

Petra Nygrén, Jonas Bouhlal, Emmi Jokinen

|Nov 03, 2023
Single-cell analysis of immune recognition in chronic myeloid leukemia patients following tyrosine kinase inhibitor discontinuation.

Jani Huuhtanen, Shady Adnan-Awad, Jason Theodoropoulos

|Dec 12, 2022
Erythroid/megakaryocytic differentiation confers BCL-XL dependency and venetoclax resistance in acute myeloid leukemia.

Heikki Kuusanmäki, Olli Dufva, Markus Vähä-Koskela

|Nov 10, 2020
Characterization of p190-Bcr-Abl chronic myeloid leukemia reveals specific signaling pathways and therapeutic targets.

Shady Adnan-Awad, Daehong Kim, Helena Hohtari

Pageof 2

Frequent Collaborators

8 joint publications

Satu Mustjoki

4 joint publications

Olli Dufva

3 joint publications

Jonas Bouhlal

3 joint publications

Matti Kankainen